Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07440121

Optimized Strict Fluid Management Helps Improve Endpoints After Liver Dissection

The Effect of Different Fluid Therapy on Major Postoperative Morbidity in Patients Undergoing Non-donor Hepatectomy: a Pilot Trial

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
90 (estimated)
Sponsor
Zhihong LU · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

During hepatectomy, surgeons often prefer to restrict fluid intake, believing that this can lower central venous pressure (CVP) and reduce intraoperative blood loss. However, fluid restriction may lead to inadequate perfusion of vital organs and even contribute to postoperative organ dysfunction, such as acute kidney injury (AKI). Therefore, this study aims to compare the effects of restrictive versus liberal fluid therapy on major complications following hepatectomy.

Conditions

Interventions

TypeNameDescription
OTHERrestrictive fluid infusionFluid infusion is restricted at 2 ml·kg- 1·h- 1 from the moment the patient arrive in the operating room to immediately after the liver lesions are removed
OTHERpreload6 ml·kg- 1·h- 1 of hydroxyethyl starch solution is infused before anesthesia
OTHERnitroNitroglycerin is infused from start of anesthesia to immediately after the liver lesions are removed.The starting infusion rates of nitroglycerin is 0.5 μg·kg- 1·min- 1 . If the speed of administration requires adjustment, nitroglycerin is added or decreased by 0.1 μg·kg- 1·min- 1.

Timeline

Start date
2026-04-02
Primary completion
2026-12-02
Completion
2027-02-02
First posted
2026-02-27
Last updated
2026-02-27

Source: ClinicalTrials.gov record NCT07440121. Inclusion in this directory is not an endorsement.